Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and ...

Currently, health plan sponsors contracted by Medicare to administer coverage of drugs under the program’s Part D benefit negotiate rebates from drugmakers, resulting in non-public net prices.

There are concerns that the negotiated drug prices under the Inflation Reduction Act (IRA) are leading to large provider ...

The government says it has "negotiated" with drugmakers to arrive at these new prices. But the process wasn't a negotiation. The federal government is simply dictating prices, which will have ...

But drugmakers are often able to extend U.S ... Each year, more drugs will be up for price negotiation by Medicare, which accounts for about a third of U.S. drug spending. "We're going to see ...

Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars ...

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly ...

Donald Trump and Kamala Harris have a rare point of agreement in their divisive contest: It’s up to the government to cut high U.S. drug prices.

But drugmakers are often able to extend U.S ... Each year, more drugs will be up for price negotiation by Medicare, which accounts for about a third of U.S. drug spending. "We're going to see ...